Bush Proposes $2.8 Billion Increase For NIH In FY2002, Vows $4.1B Next Year.
ACOR Opens Cancer-pain.org
Connie Mack Joins Washington Office Of Shaw Pittman.
Richard Wood, ICRF, Accepts Appointment At Pittsburgh.
Cancer Groups In Campaign To Draft Pazdur For FDA.
NCI Seeks 150 Advocates For Advice On Plans, Policies.
“Harm-Reduction” Products No Proven, IOM Report Says.
MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.
FDA Approves Two PSA Tests By roche; Onconase Gets EU Orphan Designation.
Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.
Response Oncology Sells Practice Back To Physicians.
EntreMed Issued U.S. Patent For Active Parts Of Endostatin.
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on - California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power - Iowa’s “cancer crisis” emerges as a top issue on the campaign trail
- Kevan Shokat made KRAS druggable. With daraxonrasib now in the clinic, he is “all in” on the ultimate target: p53
Shokat was named 2026 Stephenson Global Prize winner - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
